Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Lubiniecki

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
PDA Journal of Pharmaceutical Science and Technology|February 2, 2012
Summary of breakout session eKurt Brorson, Anthony Lubiniecki
PDA Journal of Pharmaceutical Science and Technology|November 28, 2012
PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3-4, 2011, Rockville, MDArifa S Khan, Anthony Lubiniecki, Kathryn E King
Biologicals : Journal of the International Association of Biological Standardization|November 14, 2012
Analytical lessons learned from selected therapeutic protein drug comparability studiesMarcia Federici, Anthony Lubiniecki, Prakash Manikwar, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 5, 2019
A strategic road map to filing a Biologics License Application for a pluripotent stem cell derived therapeutic productAbla A Creasey, Glyn Stacey, Kapil Bharti, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 11, 2021
A biologicals Renaissance man: John C. PetriccianiAnthony Lubiniecki, Kathryn Zoon, Richard Hill, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 8, 2016
Industry view on the relative importance of "clonality" of biopharmaceutical-producing cell linesChristopher Frye, Rohini Deshpande, Scott Estes, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 5, 2010
Comparability assessments of process and product changes made during development of two different monoclonal antibodiesAnthony Lubiniecki, David B Volkin, Marcia Federici, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 29, 2018
Report of the international conference on manufacturing and testing of pluripotent stem cellsStewart Abbot, Francisca Agbanyo, Jan-Eric Ahlfors, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
PDA Journal of Pharmaceutical Science and Technology|February 2, 2012
Summary of breakout session eKurt Brorson, Anthony Lubiniecki
PDA Journal of Pharmaceutical Science and Technology|November 28, 2012
PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3-4, 2011, Rockville, MDArifa S Khan, Anthony Lubiniecki, Kathryn E King
Biologicals : Journal of the International Association of Biological Standardization|November 14, 2012
Analytical lessons learned from selected therapeutic protein drug comparability studiesMarcia Federici, Anthony Lubiniecki, Prakash Manikwar, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 5, 2019
A strategic road map to filing a Biologics License Application for a pluripotent stem cell derived therapeutic productAbla A Creasey, Glyn Stacey, Kapil Bharti, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 11, 2021
A biologicals Renaissance man: John C. PetriccianiAnthony Lubiniecki, Kathryn Zoon, Richard Hill, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 8, 2016
Industry view on the relative importance of "clonality" of biopharmaceutical-producing cell linesChristopher Frye, Rohini Deshpande, Scott Estes, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 5, 2010
Comparability assessments of process and product changes made during development of two different monoclonal antibodiesAnthony Lubiniecki, David B Volkin, Marcia Federici, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 29, 2018
Report of the international conference on manufacturing and testing of pluripotent stem cellsStewart Abbot, Francisca Agbanyo, Jan-Eric Ahlfors, et al.
Pageof 1